BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olive C. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants. Expert Rev Vaccines 2012;11:237-56. [PMID: 22309671 DOI: 10.1586/erv.11.189] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Andrianov AK, Fuerst TR. Immunopotentiating and Delivery Systems for HCV Vaccines. Viruses 2021;13:981. [PMID: 34070543 DOI: 10.3390/v13060981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jiang L, Shao Y, Xing R, Li C, Cui Y, Zhang W, Zhao X. Identification and characterization of a novel PRR of fibrinogen-related protein in Apostichopus japonicus. Fish & Shellfish Immunology 2018;82:68-76. [DOI: 10.1016/j.fsi.2018.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stambas J, Lu C, Tripp RA. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic. Expert Rev Respir Med 2020;14:1141-7. [PMID: 32762572 DOI: 10.1080/17476348.2020.1807945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chu JQ, Gao FF, Wu W, Li C, Pan Z, Sun J, Wang H, Huang C, Lee SH, Quan JH, Lee YH. Expression profiles of NOD-like receptors and regulation of NLRP3 inflammasome activation in Toxoplasma gondii-infected human small intestinal epithelial cells. Parasit Vectors 2021;14:153. [PMID: 33712075 DOI: 10.1186/s13071-021-04666-w] [Reference Citation Analysis]
5 Ebersole JL, Orraca L, Novak MJ, Kirakodu S, Gonzalez-Martinez J, Gonzalez OA. Comparative Analysis of Gene Expression Patterns for Oral Epithelium-Related Functions with Aging. Adv Exp Med Biol 2019;1197:143-63. [PMID: 31732940 DOI: 10.1007/978-3-030-28524-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Hong W, Khampang P, Kerschner AR, Mackinnon AC, Yan K, Simpson PM, Kerschner JE. Antibiotic modulation of mucins in otitis media; should this change our approach to watchful waiting? Int J Pediatr Otorhinolaryngol 2019;125:134-40. [PMID: 31302575 DOI: 10.1016/j.ijporl.2019.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Lockner JW, Eubanks LM, Choi JL, Lively JM, Schlosburg JE, Collins KC, Globisch D, Rosenfeld-Gunn RJ, Wilson IA, Janda KD. Flagellin as carrier and adjuvant in cocaine vaccine development. Mol Pharm 2015;12:653-62. [PMID: 25531528 DOI: 10.1021/mp500520r] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
8 Choltus H, Lavergne M, De Sousa Do Outeiro C, Coste K, Belville C, Blanchon L, Sapin V. Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome. Biomedicines 2021;9:1123. [PMID: 34572309 DOI: 10.3390/biomedicines9091123] [Reference Citation Analysis]
9 Yang Q, Stevenson HL, Scott MJ, Ismail N. Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae. Am J Pathol 2015;185:446-61. [PMID: 25481711 DOI: 10.1016/j.ajpath.2014.10.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hell M, Bernhofer C, Stalzer P, Kern JM, Claassen E. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes. 2013;4:39-51. [PMID: 23434948 DOI: 10.3920/bm2012.0049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
11 Song L, Xiong D, Kang X, Jiao Y, Zhou X, Wu K, Zhou Y, Jiao X, Pan Z. The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice. Antiviral Res 2019;161:10-9. [PMID: 30389471 DOI: 10.1016/j.antiviral.2018.10.027] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Pitoiset F, Vazquez T, Levacher B, Nehar-Belaid D, Dérian N, Vigneron J, Klatzmann D, Bellier B. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation. J Virol 2017;91:e01230-17. [PMID: 28794025 DOI: 10.1128/JVI.01230-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chu JQ, Shi G, Fan YM, Choi IW, Cha GH, Zhou Y, Lee YH, Quan JH. Production of IL-1β and Inflammasome with Up-Regulated Expressions of NOD-Like Receptor Related Genes in Toxoplasma gondii-Infected THP-1 Macrophages. Korean J Parasitol 2016;54:711-7. [PMID: 28095655 DOI: 10.3347/kjp.2016.54.6.711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
14 Liniger M, Summerfield A, Ruggli N. MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens. PLoS One 2012;7:e49952. [PMID: 23227156 DOI: 10.1371/journal.pone.0049952] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
15 Robinson JA, Moehle K. Structural aspects of molecular recognition in the immune system. Part II: Pattern recognition receptors (IUPAC Technical Report). Pure and Applied Chemistry 2014;86:1483-538. [DOI: 10.1515/pac-2013-1026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
16 Škrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzmán CA. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS One 2014;9:e95728. [PMID: 24755640 DOI: 10.1371/journal.pone.0095728] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
17 Singh VV, Chauhan SK, Rai R, Kumar A, Rai G. Decreased toll-like receptor-4/myeloid differentiation factor 88 response leads to defective interleukin-1β production in term low birth weight newborns. Pediatr Infect Dis J 2014;33:1270-6. [PMID: 25389708 DOI: 10.1097/INF.0000000000000416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Szabo A. Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities. Front Immunol 2015;6:358. [PMID: 26236313 DOI: 10.3389/fimmu.2015.00358] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
19 Wilson KL, Howard GP, Coatsworth H, Dinglasan RR, Mao HQ, Plebanski M. Biodegradable PLGA-b-PEG Nanoparticles Induce T Helper 2 (Th2) Immune Responses and Sustained Antibody Titers via TLR9 Stimulation. Vaccines (Basel) 2020;8:E261. [PMID: 32485944 DOI: 10.3390/vaccines8020261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Magiri R, Mutwiri G, Wilson HL. Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action. Cell Tissue Res 2018;374:465-71. [PMID: 30294754 DOI: 10.1007/s00441-018-2929-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
21 Martínez I, Oliveros JC, Cuesta I, de la Barrera J, Ausina V, Casals C, de Lorenzo A, García E, García-Fojeda B, Garmendia J, González-Nicolau M, Lacoma A, Menéndez M, Moranta D, Nieto A, Ortín J, Pérez-González A, Prat C, Ramos-Sevillano E, Regueiro V, Rodriguez-Frandsen A, Solís D, Yuste J, Bengoechea JA, Melero JA. Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens. Front Microbiol 2017;8:276. [PMID: 28298903 DOI: 10.3389/fmicb.2017.00276] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
22 Monzavi-Karbassi B, Pashov A, Kieber-Emmons T. Tumor-Associated Glycans and Immune Surveillance. Vaccines (Basel) 2013;1:174-203. [PMID: 26343966 DOI: 10.3390/vaccines1020174] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
23 Schechter MC, Satola SW, Stephens DS. Host Defenses to Extracellular Bacteria. Clinical Immunology. Elsevier; 2019. pp. 391-402.e1. [DOI: 10.1016/b978-0-7020-6896-6.00027-2] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Circelli L, Tornesello M, Buonaguro FM, Buonaguro L. Use of adjuvants for immunotherapy. Hum Vaccin Immunother 2017;13:1774-7. [PMID: 28604160 DOI: 10.1080/21645515.2017.1321725] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
25 Zhang B, Yin Y, Lai RC, Lim SK. Immunotherapeutic potential of extracellular vesicles. Front Immunol 2014;5:518. [PMID: 25374570 DOI: 10.3389/fimmu.2014.00518] [Cited by in Crossref: 83] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
26 Liu C, Chu X, Yan M, Qi J, Liu H, Gao F, Gao R, Ma G, Ma Y. Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors. Int J Pharm 2018;553:327-37. [PMID: 30393151 DOI: 10.1016/j.ijpharm.2018.10.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
27 Mittal R, Kodiyan J, Gerring R, Mathee K, Li JD, Grati M, Liu XZ. Role of innate immunity in the pathogenesis of otitis media. Int J Infect Dis 2014;29:259-67. [PMID: 25447732 DOI: 10.1016/j.ijid.2014.10.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
28 Pedersen GK, Andersen P, Christensen D. Immunocorrelates of CAF family adjuvants. Seminars in Immunology 2018;39:4-13. [DOI: 10.1016/j.smim.2018.10.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
29 Moyle PM, Toth I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem 2013;8:360-76. [PMID: 23316023 DOI: 10.1002/cmdc.201200487] [Cited by in Crossref: 205] [Cited by in F6Publishing: 195] [Article Influence: 22.8] [Reference Citation Analysis]
30 Flower DR. Systematic identification of small molecule adjuvants. Expert Opin Drug Discov 2012;7:807-17. [PMID: 22724523 DOI: 10.1517/17460441.2012.699958] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
31 Apostólico Jde S, Lunardelli VA, Coirada FC, Boscardin SB, Rosa DS. Adjuvants: Classification, Modus Operandi, and Licensing. J Immunol Res 2016;2016:1459394. [PMID: 27274998 DOI: 10.1155/2016/1459394] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 14.0] [Reference Citation Analysis]
32 Tada R, Yamanaka D, Ogasawara M, Saito M, Ohno N, Kiyono H, Kunisawa J, Aramaki Y. Polymeric Caffeic Acid Is a Safer Mucosal Adjuvant That Augments Antigen-Specific Mucosal and Systemic Immune Responses in Mice. Mol Pharm 2018;15:4226-34. [PMID: 30107747 DOI: 10.1021/acs.molpharmaceut.8b00648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Mosaheb MM, Reiser ML, Wetzler LM. Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production. Front Immunol 2017;8:225. [PMID: 28316602 DOI: 10.3389/fimmu.2017.00225] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
34 Choudhuri S, Chowdhury IH, Garg NJ. Mitochondrial Regulation of Macrophage Response Against Pathogens. Front Immunol 2020;11:622602. [PMID: 33679710 DOI: 10.3389/fimmu.2020.622602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Banday AH, Jeelani S, Hruby VJ. Cancer vaccine adjuvants--recent clinical progress and future perspectives. Immunopharmacol Immunotoxicol 2015;37:1-11. [PMID: 25318595 DOI: 10.3109/08923973.2014.971963] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
36 Chen C, Hsu H, Hudgens E, Telfer JC, Baldwin CL. Signal transduction by different forms of the γδ T cell-specific pattern recognition receptor WC1. J Immunol 2014;193:379-90. [PMID: 24850725 DOI: 10.4049/jimmunol.1400168] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
37 Chai D, Yue Y, Xu W, Dong C, Xiong S. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis. Hum Vaccin Immunother 2014;10:1284-94. [PMID: 24614684 DOI: 10.4161/hv.28333] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
38 Gąsiorowski K, Brokos B, Echeverria V, Barreto GE, Leszek J. RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration. Mol Neurobiol 2018;55:1463-76. [PMID: 28168427 DOI: 10.1007/s12035-017-0419-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
39 Tong C, Cui Z, Sun X, Lei L, Feng X, Sun C, Gu J, Han W. Mannan Derivatives Instruct Dendritic Cells to Induce Th1/Th2 Cells Polarization via Differential Mitogen-Activated Protein Kinase Activation. Scand J Immunol 2016;83:10-7. [PMID: 26332129 DOI: 10.1111/sji.12369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Kardani K, Sadat SM, Kardani M, Bolhassani A. The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Rev Vaccines 2021;20:839-55. [PMID: 34114513 DOI: 10.1080/14760584.2021.1941895] [Reference Citation Analysis]
41 Liu C, Ye X. Carbohydrate-based cancer vaccines: target cancer with sugar bullets. Glycoconj J 2012;29:259-71. [DOI: 10.1007/s10719-012-9399-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
42 Wei MM, Wang YS, Ye XS. Carbohydrate-based vaccines for oncotherapy. Med Res Rev 2018;38:1003-26. [PMID: 29512174 DOI: 10.1002/med.21493] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
43 Moody MA, Santra S, Vandergrift NA, Sutherland LL, Gurley TC, Drinker MS, Allen AA, Xia SM, Meyerhoff RR, Parks R, Lloyd KE, Easterhoff D, Alam SM, Liao HX, Ward BM, Ferrari G, Montefiori DC, Tomaras GD, Seder RA, Letvin NL, Haynes BF. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. J Virol 2014;88:3329-39. [PMID: 24390332 DOI: 10.1128/JVI.03309-13] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
44 Orr MT, Beebe EA, Hudson TE, Moon JJ, Fox CB, Reed SG, Coler RN. A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93. PLoS One. 2014;9:e83884. [PMID: 24404140 DOI: 10.1371/journal.pone.0083884] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
45 Martin-Bertelsen B, Korsholm KS, Roces CB, Nielsen MH, Christensen D, Franzyk H, Yaghmur A, Foged C. Nano-Self-Assemblies Based on Synthetic Analogues of Mycobacterial Monomycoloyl Glycerol and DDA: Supramolecular Structure and Adjuvant Efficacy. Mol Pharm 2016;13:2771-81. [PMID: 27377146 DOI: 10.1021/acs.molpharmaceut.6b00368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
46 Al Mamun A, Mimi AA, Zaeem M, Wu Y, Monalisa I, Akter A, Munir F, Xiao J. Role of pyroptosis in diabetic retinopathy and its therapeutic implications. Eur J Pharmacol 2021;904:174166. [PMID: 33979651 DOI: 10.1016/j.ejphar.2021.174166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kaur D, Arora C, Raghava GPS. A Hybrid Model for Predicting Pattern Recognition Receptors Using Evolutionary Information. Front Immunol 2020;11:71. [PMID: 32082326 DOI: 10.3389/fimmu.2020.00071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Lorenzo G, Rodríguez-Pulido M, López-Gil E, Sobrino F, Borrego B, Sáiz M, Brun A. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome. Antiviral Res 2014;109:64-7. [PMID: 24973761 DOI: 10.1016/j.antiviral.2014.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
49 Borrego B, Rodríguez-Pulido M, Revilla C, Álvarez B, Sobrino F, Domínguez J, Sáiz M. Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation. Viruses 2015;7:3954-73. [PMID: 26193305 DOI: 10.3390/v7072807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
50 Brun A. Vaccines and Vaccination for Veterinary Viral Diseases: A General Overview. Methods Mol Biol 2016;1349:1-24. [PMID: 26458826 DOI: 10.1007/978-1-4939-3008-1_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
51 Guo X, Wu N, Shang Y, Liu X, Wu T, Zhou Y, Liu X, Huang J, Liao X, Wu L. The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells. Front Immunol 2017;8:158. [PMID: 28270814 DOI: 10.3389/fimmu.2017.00158] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
52 Schotsaert M, Saelens X, Leroux-Roels G. Influenza vaccines: T-cell responses deserve more attention. Expert Rev Vaccines 2012;11:949-62. [PMID: 23002976 DOI: 10.1586/erv.12.71] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
53 Nolan MB, Schulman ML, Botha AE, Human A, Roth R, Crampton MC, Bertschinger HJ. Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund’s adjuvant in horses. Vaccine 2019;37:1299-306. [DOI: 10.1016/j.vaccine.2019.01.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Borrego B, Rodríguez-Pulido M, Mateos F, de la Losa N, Sobrino F, Sáiz M. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice. Vaccine 2013;31:4375-81. [PMID: 23859841 DOI: 10.1016/j.vaccine.2013.07.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
55 Cong J, Gong J, Yang C, Xia Z, Zhang H. miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3. Cancer Manag Res 2020;12:5419-29. [PMID: 32753959 DOI: 10.2147/CMAR.S255125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Biondo C, Lentini G, Beninati C, Teti G. The dual role of innate immunity during influenza. Biomed J 2019;42:8-18. [PMID: 30987709 DOI: 10.1016/j.bj.2018.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
57 Robinson JA. Max Bergmann lecture protein epitope mimetics in the age of structural vaccinology. J Pept Sci 2013;19:127-40. [PMID: 23349031 DOI: 10.1002/psc.2482] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
58 Circelli L, Petrizzo A, Tagliamonte M, Heidenreich R, Tornesello ML, Buonaguro FM, Buonaguro L. Immunological effects of a novel RNA-based adjuvant in liver cancer patients. Cancer Immunol Immunother. 2017;66:103-112. [PMID: 27832318 DOI: 10.1007/s00262-016-1923-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
59 Cordeiro AS, Alonso MJ. Recent advances in vaccine delivery. Pharm Pat Anal 2016;5:49-73. [PMID: 26667309 DOI: 10.4155/ppa.15.38] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
60 Waeckerle-Men Y, Mauracher A, Håkerud M, Mohanan D, Kündig TM, Høgset A, Johansen P. Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses. Eur J Pharm Biopharm 2013;85:34-41. [PMID: 23461859 DOI: 10.1016/j.ejpb.2013.02.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
61 Kabel AM, Arab HH, Abd Elmaaboud MA. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis. Hum Exp Toxicol 2021;40:1710-20. [PMID: 33840231 DOI: 10.1177/09603271211008496] [Reference Citation Analysis]
62 Kennedy RB, Ovsyannikova IG, Lambert ND, Haralambieva IH, Poland GA. The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines 2014;13:657-69. [PMID: 24702429 DOI: 10.1586/14760584.2014.905744] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
63 Quan JH, Huang R, Wang Z, Huang S, Choi IW, Zhou Y, Lee YH, Chu JQ. P2X7 receptor mediates NLRP3-dependent IL-1β secretion and parasite proliferation in Toxoplasma gondii-infected human small intestinal epithelial cells. Parasit Vectors 2018;11:1. [PMID: 29291748 DOI: 10.1186/s13071-017-2573-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 11.5] [Reference Citation Analysis]
64 Grabacka M, Pierzchalska M, Płonka PM, Pierzchalski P. The Role of PPAR Alpha in the Modulation of Innate Immunity. Int J Mol Sci 2021;22:10545. [PMID: 34638886 DOI: 10.3390/ijms221910545] [Reference Citation Analysis]
65 Gause KT, Wheatley AK, Cui J, Yan Y, Kent SJ, Caruso F. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS Nano 2017;11:54-68. [PMID: 28075558 DOI: 10.1021/acsnano.6b07343] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 19.6] [Reference Citation Analysis]
66 Zhu M, Ding X, Zhao R, Liu X, Shen H, Cai C, Ferrari M, Wang HY, Wang RF. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma. J Control Release 2018;272:72-82. [PMID: 29325699 DOI: 10.1016/j.jconrel.2018.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
67 Hayashi M, Aoshi T, Haseda Y, Kobiyama K, Wijaya E, Nakatsu N, Igarashi Y, Standley DM, Yamada H, Honda-Okubo Y, Hara H, Saito T, Takai T, Coban C, Petrovsky N, Ishii KJ. Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines. EBioMedicine 2017;15:127-36. [PMID: 27919753 DOI: 10.1016/j.ebiom.2016.11.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
68 Zhu Z, Zhang X, Wang G, Zheng H. The laboratory of genetics and physiology 2: emerging insights into the controversial functions of this RIG-I-like receptor. Biomed Res Int 2014;2014:960190. [PMID: 24551857 DOI: 10.1155/2014/960190] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
69 Li G, Xue H, Fan Z, Bai Y. Impact of heme on specific antibody production in mice: promotive, inhibitive or null outcome is determined by its concentration. Heliyon 2017;3:e00303. [PMID: 28560357 DOI: 10.1016/j.heliyon.2017.e00303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 David SA. Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins. Front Immunol 2012;3:252. [PMID: 22912638 DOI: 10.3389/fimmu.2012.00252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
71 Del Principe D, Lista P, Malorni W, Giammarioli AM. Fibroblast autophagy in fibrotic disorders. J Pathol 2013;229:208-20. [PMID: 23018629 DOI: 10.1002/path.4115] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
72 Ahn SY, Le CTT, Ko EJ. Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Ovalbumin-Specific Cell Mediated Immunity in Mice Model. Biology (Basel) 2021;10:908. [PMID: 34571785 DOI: 10.3390/biology10090908] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Platt A, MacLeod H, Massari P, Liu X, Wetzler L. In vivo and in vitro characterization of the immune stimulating activity of the Neisserial porin PorB. PLoS One 2013;8:e82171. [PMID: 24349212 DOI: 10.1371/journal.pone.0082171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
74 Verhelst K, Verstrepen L, Carpentier I, Beyaert R. IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer. Biochem Pharmacol 2013;85:873-80. [PMID: 23333767 DOI: 10.1016/j.bcp.2013.01.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 7.3] [Reference Citation Analysis]
75 Weilhammer DR, Blanchette CD, Fischer NO, Alam S, Loots GG, Corzett M, Thomas C, Lychak C, Dunkle AD, Ruitenberg JJ, Ghanekar SA, Sant AJ, Rasley A. The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge. Biomaterials 2013;34:10305-18. [PMID: 24075406 DOI: 10.1016/j.biomaterials.2013.09.038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
76 Godwin JW, Pinto AR, Rosenthal NA. Chasing the recipe for a pro-regenerative immune system. Semin Cell Dev Biol 2017;61:71-9. [PMID: 27521522 DOI: 10.1016/j.semcdb.2016.08.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
77 Li M, Wang Y, Sun Y, Cui H, Zhu SJ, Qiu HJ. Mucosal vaccines: Strategies and challenges. Immunol Lett 2020;217:116-25. [PMID: 31669546 DOI: 10.1016/j.imlet.2019.10.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
78 Chai D, Yue Y, Xu W, Dong C, Xiong S. AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis. Antiviral Res 2015;119:68-77. [PMID: 25956163 DOI: 10.1016/j.antiviral.2015.04.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
79 de Morais CG, Castro Lima AK, Terra R, dos Santos RF, Da-Silva SA, Dutra PM. The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection. Biomed Res Int 2015;2015:324915. [PMID: 26090399 DOI: 10.1155/2015/324915] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
80 Atapour A, Mokarram P, Mostafavipour Z, Hosseini SY, Ghasemi Y, Mohammadi S, Nezafat N. Designing a Fusion Protein Vaccine Against HCV: An In Silico Approach. Int J Pept Res Ther 2019;25:861-72. [DOI: 10.1007/s10989-018-9735-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]